🇺🇸 Simdax in United States
42 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 42
Most-reported reactions
- Hypotension — 9 reports (21.43%)
- Death — 7 reports (16.67%)
- Cardiac Failure — 6 reports (14.29%)
- Blood Creatinine Increased — 3 reports (7.14%)
- Contraindicated Product Administered — 3 reports (7.14%)
- Myoglobinaemia — 3 reports (7.14%)
- Pulmonary Haemorrhage — 3 reports (7.14%)
- Ventricular Tachycardia — 3 reports (7.14%)
- Weight Increased — 3 reports (7.14%)
- Acute Kidney Injury — 2 reports (4.76%)
Other Cardiovascular approved in United States
Frequently asked questions
Is Simdax approved in United States?
Simdax does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Simdax in United States?
Yooyoung Pharmaceutical Co., Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.